Medicinal Products

Lucentis

Name Lucentis
Active Substance ranibizumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code S01LA04
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Brošura za zdravstvene radnike, verzija 4
Educational materials
for patients / caregivers
Brošura za bolesnike dijabetički makularni edem, verzija 3
Brošura za bolesnike neovaskularizacija žilnice, verzija 3
Brošura za bolesnike neovaskularna senilna makularna degeneracija, verzija 3
Brošura za bolesnike začepljenja vene u pozadini mrežnice, verzija 3

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/lucentis

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Back